Short Interest in BlackRock Health Sciences Term Trust (NYSE:BMEZ) Expands By 1,452.2%

BlackRock Health Sciences Term Trust (NYSE:BMEZGet Free Report) saw a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 142,800 shares, a growth of 1,452.2% from the January 15th total of 9,200 shares. Based on an average daily trading volume, of 554,500 shares, the short-interest ratio is presently 0.3 days.

BlackRock Health Sciences Term Trust Trading Up 0.8 %

BMEZ stock opened at 16.11 on Tuesday. BlackRock Health Sciences Term Trust has a 12 month low of 12.93 and a 12 month high of 16.95. The firm has a 50-day moving average of 14.96 and a two-hundred day moving average of 14.69.

BlackRock Health Sciences Term Trust Cuts Dividend

The business also recently disclosed a monthly dividend, which will be paid on Thursday, February 29th. Shareholders of record on Thursday, February 15th will be given a dividend of $0.09 per share. The ex-dividend date is Wednesday, February 14th. This represents a $1.08 dividend on an annualized basis and a yield of 6.70%.

Insider Buying and Selling

In other news, major shareholder Saba Capital Management, L.P. acquired 95,390 shares of BlackRock Health Sciences Term Trust stock in a transaction that occurred on Friday, November 17th. The shares were bought at an average cost of 13.59 per share, with a total value of 1,296,350.10. Following the transaction, the insider now directly owns 13,322,293 shares of the company’s stock, valued at approximately 181,049,961.87. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In the last quarter, insiders bought 3,742,279 shares of company stock valued at $54,740,610.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

Several hedge funds have recently bought and sold shares of the company. PNC Financial Services Group Inc. increased its position in BlackRock Health Sciences Term Trust by 3.9% during the second quarter. PNC Financial Services Group Inc. now owns 21,210 shares of the company’s stock worth $348,000 after buying an additional 795 shares in the last quarter. B. Riley Wealth Advisors Inc. raised its position in BlackRock Health Sciences Term Trust by 4.8% in the third quarter. B. Riley Wealth Advisors Inc. now owns 17,363 shares of the company’s stock valued at $250,000 after purchasing an additional 796 shares during the period. Pine Valley Investments Ltd Liability Co increased its position in shares of BlackRock Health Sciences Term Trust by 6.7% during the fourth quarter. Pine Valley Investments Ltd Liability Co now owns 13,088 shares of the company’s stock worth $192,000 after acquiring an additional 822 shares during the last quarter. Benjamin F. Edwards & Company Inc. increased its holdings in BlackRock Health Sciences Term Trust by 24.1% in the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 4,792 shares of the company’s stock valued at $70,000 after buying an additional 930 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. increased its holdings in BlackRock Health Sciences Term Trust by 0.6% in the third quarter. Raymond James Financial Services Advisors Inc. now owns 186,566 shares of the company’s stock valued at $2,688,000 after buying an additional 1,041 shares during the last quarter.

BlackRock Health Sciences Term Trust Company Profile

(Get Free Report)

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.

Featured Articles

Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.